Kingworld Medicines Group Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Li Sheng Zhao
Chief executive officer
CN¥1.4m
Total compensation
CEO salary percentage | 97.9% |
CEO tenure | 15.6yrs |
CEO ownership | 51.4% |
Management average tenure | no data |
Board average tenure | 14yrs |
Recent management updates
Recent updates
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | CN¥38m |
Sep 30 2023 | n/a | n/a | CN¥37m |
Jun 30 2023 | n/a | n/a | CN¥36m |
Mar 31 2023 | n/a | n/a | CN¥29m |
Dec 31 2022 | CN¥1m | CN¥1m | CN¥23m |
Sep 30 2022 | n/a | n/a | CN¥29m |
Jun 30 2022 | n/a | n/a | CN¥35m |
Mar 31 2022 | n/a | n/a | CN¥33m |
Dec 31 2021 | CN¥1m | CN¥1m | CN¥30m |
Sep 30 2021 | n/a | n/a | CN¥26m |
Jun 30 2021 | n/a | n/a | CN¥21m |
Mar 31 2021 | n/a | n/a | CN¥17m |
Dec 31 2020 | CN¥1m | CN¥1m | CN¥12m |
Sep 30 2020 | n/a | n/a | CN¥16m |
Jun 30 2020 | n/a | n/a | CN¥20m |
Mar 31 2020 | n/a | n/a | CN¥32m |
Dec 31 2019 | CN¥2m | CN¥2m | CN¥43m |
Sep 30 2019 | n/a | n/a | CN¥45m |
Jun 30 2019 | n/a | n/a | CN¥46m |
Mar 31 2019 | n/a | n/a | CN¥44m |
Dec 31 2018 | CN¥1m | CN¥1m | CN¥41m |
Sep 30 2018 | n/a | n/a | CN¥49m |
Jun 30 2018 | n/a | n/a | CN¥56m |
Mar 31 2018 | n/a | n/a | CN¥54m |
Dec 31 2017 | CN¥2m | CN¥1m | CN¥51m |
Compensation vs Market: Li Sheng's total compensation ($USD192.61K) is about average for companies of similar size in the Hong Kong market ($USD233.25K).
Compensation vs Earnings: Li Sheng's compensation has been consistent with company performance over the past year.
CEO
Li Sheng Zhao (65 yo)
15.6yrs
Tenure
CN¥1,394,000
Compensation
Mr. Zhao Li Sheng is a Co-founder of Kingworld Medicines Group Limited and serves as its Chief Executive Officer. Mr. Zhao is responsible for Kingworld Medicines Group's overall strategic planning and busi...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.6yrs | CN¥1.39m | 51.42% CN¥ 163.2m | |
Co-Founder & Executive Director | 15.6yrs | CN¥1.25m | 14.47% CN¥ 45.9m | |
Executive Director | 14.7yrs | CN¥503.00k | 0.39% CN¥ 1.2m | |
Independent Non-Executive Director | 13.4yrs | CN¥276.00k | no data | |
Independent Non-Executive Director | 13.4yrs | CN¥276.00k | no data | |
Independent Non-Executive Director | 10.7yrs | CN¥276.00k | 0.0058% CN¥ 18.4k |
14.0yrs
Average Tenure
59yo
Average Age
Experienced Board: 1110's board of directors are seasoned and experienced ( 14 years average tenure).